Clinical Trial: A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775924) titled 'A Study to Assess the Efficacy and Safety of GIA632 Across a Range of Doses in Participants With Moderate to Severe Cutaneous Lichen Planus' on Aug. 17.

Brief Summary: This study will evaluate the safety and efficacy of GIA632 in participants with moderate to severe cutaneous lichen planus (cLP).

Study Start Date: Sept. 10

Study Type: INTERVENTIONAL

Condition: Cutaneous Lichen Planus

Intervention: DRUG: Placebo

Matching placebo

DRUG: GIA632

GIA632 administered according to the assigned study treatment regimen.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Published by HT Digital Content Service...